TMCLIFE | TMC LIFE SCIENCES BERHAD

6
0.720 (1.41%)

T-O (am): 0.710 (08:59:00)
Last updated: 17:00

Fundamental
Technical
Total Score

TMCLIFE | TMC LIFE SCIENCES BERHAD


iSaham Fundamental Trend

FCON: | Sharpe Ratio: | LTS:


Quarter Reports

Chart:

Select columns required and click "Update" to save your preferences

Ann. Date Qtr. Date Q FYE Revenue [M] PBT [M] NP [M] NPM DPS EPS R. QoQ R. YoY E. QoQ E. YoY TTM
EPS
Adj.
[M]
NP [M]
(adj)
NPM
(adj)
EPS
(adj)
E. QoQ
(adj)
E. YoY
(adj)
TTM EPS
(adj)
02 Feb 24 Q2 Dec 23 2 30 Jun 24 93.78 19.68 14.52 15.5% 0.00 0.83 1.5% 27.9% 4.1% 164.6%
14 Nov 23 Q1 Sep 23 1 30 Jun 24 92.44 20.14 15.14 16.4% 0.00 0.87 9.2% 28.6% 14.3% 143.1%
22 Aug 23 Q4 Jun 23 4 30 Jun 23 84.65 12.59 13.24 15.7% 0.84 0.76 3.8% 19.6% 7.3% 43.6%
23 May 23 Q3 Mar 23 3 30 Jun 23 81.58 11.89 14.29 17.5% 0.00 0.82 11.2% 33.6% 160.4% 105.1%
08 Feb 23 Q2 Dec 22 2 30 Jun 23 73.34 7.68 5.49 7.5% 0.00 0.32 2.0% 23.9% 11.8% 20.5%
16 Nov 22 Q1 Sep 22 1 30 Jun 23 71.87 8.73 6.23 8.7% 0.00 0.36 1.5% 36.4% 73.5% 53.9%
23 Aug 22 Q4 Jun 22 4 30 Jun 22 70.80 10.35 23.47 33.1% 0.28 1.35 15.9% 32.6% 236.8% 525.3%
26 May 22 Q3 Mar 22 3 30 Jun 22 61.08 7.46 6.97 11.4% 0.00 0.40 3.1% 27.2% 0.9% 110.2%
09 Feb 22 Q2 Dec 21 2 30 Jun 22 59.22 9.05 6.91 11.7% 0.00 0.40 12.4% 21.4% 70.7% 27.9%
09 Nov 21 Q1 Sep 21 1 30 Jun 22 52.68 5.32 4.05 7.7% 0.00 0.23 1.3% 3.6% 7.8% 48.0%
24 Aug 21 Q4 Jun 21 4 30 Jun 21 53.37 5.70 3.75 7.0% 0.22 0.22 11.1% 253.3% 13.2% 34.0%
25 May 21 Q3 Mar 21 3 30 Jun 21 48.03 4.37 3.32 6.9% 0.00 0.19 1.6% 37.7% 38.6% 177.1%
04 Feb 21 Q2 Dec 20 2 30 Jun 21 48.79 6.98 5.40 11.1% 0.00 0.31 4.0% 4.1% 30.6% 20.8%
10 Nov 20 Q1 Sep 20 1 30 Jun 21 50.83 10.62 7.78 15.3% 0.00 0.45 236.5% 3.2% 178.0% 2.1%
25 Aug 20 30 Jun 20 Other 30 Jun 20 15.11 3.68 2.80 18.5% 0.17 0.16 56.7% 70.7% 165.1% 56.7%
28 Jul 20 31 May 20 Other 30 Jun 20 34.87 -4.55 -4.30 -12.3% 0.00 -0.25 31.5% 31.8% 163.0% 151.5%
28 Apr 20 29 Feb 20 Other 30 Jun 20 50.89 8.63 6.82 13.4% 0.00 0.39 3.1% 12.7% 14.2% 9.9%
09 Jan 20 30 Nov 19 Other 30 Jun 20 52.53 10.66 7.95 15.1% 0.00 0.46 2.0% 11.4% 23.1% 12.5%
24 Oct 19 Q4 Aug 19 4 31 Aug 19 51.52 9.63 6.46 12.5% 0.20 0.37 0.8% 16.0% 22.7% 14.9%
26 Jul 19 Q3 May 19 3 31 Aug 19 51.13 10.89 8.36 16.3% 0.00 0.48 13.2% 28.8% 34.7% 75.6%
23 Apr 19 Q2 Feb 19 2 31 Aug 19 45.16 8.22 6.21 13.7% 0.00 0.36 4.2% 8.2% 12.2% 1.9%
24 Jan 19 Q1 Nov 18 1 31 Aug 19 47.16 9.41 7.07 15.0% 0.00 0.41 6.2% 20.0% 25.6% 36.3%
26 Jul 18 Q3 May 18 3 31 Aug 18 44.41 8.00 5.63 12.7% 0.00 0.32 11.8% 9.1% 18.2% 5.5%
30 Apr 18 Q2 Feb 18 2 31 Aug 18 39.71 6.40 4.76 12.0% 0.00 0.27 4.8% 11.8% 24.8% 4.8%
29 Jan 18 Q1 Nov 17 1 31 Aug 18 41.73 8.32 6.33 15.2% 0.00 0.36 6.2% 15.3% 43.0% 42.6%
26 Oct 17 Q4 Aug 17 4 31 Aug 17 39.31 6.75 11.10 28.2% 0.17 0.64 3.4% 16.3% 86.3% 89.0%
27 Jul 17 Q3 May 17 3 31 Aug 17 40.69 8.02 5.96 14.6% 0.00 0.34 14.6% 16.6% 31.1% 10.5%
28 Apr 17 Q2 Feb 17 2 31 Aug 17 35.51 6.27 4.54 12.8% 0.00 0.26 1.9% 13.1% 2.4% 38.8%
23 Jan 17 Q1 Nov 16 1 31 Aug 17 36.20 6.11 4.44 12.3% 0.00 0.26 7.1% 15.5% 24.4% 33.0%
28 Oct 16 31 Aug 16 Other 31 Aug 16 33.80 5.42 5.87 17.4% 0.15 0.34 3.2% 12.4% 8.9% 102.8%
28 Jul 16 31 May 16 Other 31 Aug 16 34.91 6.43 5.39 15.4% 0.00 0.32 11.2% 22.5% 64.5% 35.3%
21 Apr 16 29 Feb 16 Other 31 Aug 16 31.39 4.85 3.27 10.4% 0.00 0.21 0.2% 18.8% 1.9% 12.7%
22 Jan 16 30 Nov 15 Other 31 Aug 16 31.33 4.88 3.34 10.7% 0.00 0.24 4.2% 24.8% 15.3% 44.7%
21 Oct 15 31 Aug 15 Other 31 Aug 16 30.07 4.35 2.89 9.6% 0.00 0.24 5.5% 29.8% 27.3% 297.5%
24 Jul 15 Q4 May 15 4 31 May 15 28.50 2.64 3.98 14.0% 0.14 0.40 7.9% 17.7% 37.0% 48.5%
22 Apr 15 Q3 Feb 15 3 31 May 15 26.41 3.20 2.91 11.0% 0.00 0.32 5.2% 19.5% 26.0% 66.7%
22 Jan 15 30/11/14 2 31/05/15 25.10 2.12 2.31 9.2% 0.00 0.28 8.3% 10.8% 216.9% 3.9%

Historical Dividends

Financial Ratios

EPS 3.3 sen
Trailing PE (Sector Median: 22.8) 21.8
PEG 0.22
Altman Z 0.8
Beaver 0.16
Current Ratio 1.96
Debt-Equity (DE) Ratio 0.36
FCF Yield 3.34 %
Revenue QoQ 1.46 %
Revenue YoY 27.87%
Profit QoQ -4.07 %
Profit YoY 164.55 %
Profit Margin (Sector Median: 7.4) 16.23 %
ROE (ROIC: 5.34) 6.52 %
Dividend Per Share (DPS) 0.84 sen
Dividend Yield (DY) 1.17 %

Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 22.8)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 7.4)
ROE (ROIC: 5.36)
Altman Z

Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF) 5% Growth
Discounted Cash Flow (DCF) 10% Growth
Relative Valuation
Graham Formula
Graham Number
Net Tangible Asset (NTA) 0.5
Consistent QR FV
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 14.56
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 319.15
Expected Revenue (M) 2690.98
Expected Growth (%) 43.0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

Directors Share Purchases (Beta)


No transaction in the last 2 months.

Summary


Market Cap: 1249 M.

Number of Shares: 1736 M.

Adjusted Float: 100%.

Stock highly correlated with

UNIQUE (90%)

EDARAN (89%)

TEOSENG (89%)

PBA (88%)

TMC Life Sciences Berhad, through its subsidiaries, provides a range of fertility treatment services in Malaysia. It is engaged in the development, marketing, management of healthcare programs; provision of storage of cord blood and adult stem cells, stem cell therapy, and application services. It operates women's clinic and medical center; and provides gynecological and fertility problem management, as well as consultancy, and research and development services. The company operates TMC fertility centers. The company was founded in 1994 and is headquartered in Petaling Jaya, Malaysia.

Sectors: Trading & Services, Healthcare, Health Care Providers

Code: 0101

Website: http://www.tmclife.com/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.